Integrative Medicine
RSSArticles
-
Internal Medicine Alert - Full November 15, 2009 Issue in PDF
-
Alternative Medicine Alert - Full December 1, 2009 Issue in PDF
-
Primary Care Reports - Full February 2010 Issue in PDF
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Results from a Phase 3 study of dabigatran, intensive lipid-lowering in CVD, H1N1 vaccine dosing and efficacy, and FDA Actions -
Medical Advances in the Evaluation and Treatment of Heart Failure
Congestive heart failure (CHF) is the most common DRG for Medicare patients in U.S. hospitals and is therefore the target of considerable regulatory attention due to its financial impact on the federal budget. -
Fatigue Follow-up
After 1 year, fewer than half of patients presenting with fatigue will have a diagnosis. -
Clinical Briefs by Louis Kuritzky, MD
-
Effects of High- vs Low- dose ARBs on Outcomes in Patients with CHF
Losartan 150 mg/day reduced left ventricular ejection fraction, intolerance to ACE inhibitors, and the rate of death and/or hospital admission for heart failure in patients with CHF more than did losartan 50 mg/day, thereby demonstrating the potential value of uptitrating ARB doses to confer clinical benefit. -
Internal Medicine Alert - Full January 29, 2010 Issue in PDF